This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,571.60 firm fixed-price delivery order is for the supply of NUCALA 100 MG/ML AUTO-INJECTOR pharmaceutical products.
The award is part of a larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. This single-award IDC allows DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds this IDC as a prime vendor, providing both routine and critical medications to support the diverse medical needs of the Department of Defense (DoD) healthcare system.
The contract has no set-aside designation, as DMS Pharmaceutical Group's status as a woman-owned small business enables the company to secure direct awards for pharmaceutical Prime Vendor programs supporting military medical facilities globally.
Generated 12/26/24, 9:22 AM